e-learning
resources
Vienna 2009
Wednesday, 16.09.2009
Asthma assessment and original therapeutic approaches
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Severity, control and treatment of a cohort of aspirin-sensitive asthmatics (ASA)
G. Bochenek, J. Kuschill-Dziurda, D. Dziurda, E. Nizankowska-Mogilnicka, A. Szczeklik (Krakow, Poland)
Source:
Annual Congress 2009 - Asthma assessment and original therapeutic approaches
Session:
Asthma assessment and original therapeutic approaches
Session type:
E-Communication Session
Number:
4564
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Bochenek, J. Kuschill-Dziurda, D. Dziurda, E. Nizankowska-Mogilnicka, A. Szczeklik (Krakow, Poland). Severity, control and treatment of a cohort of aspirin-sensitive asthmatics (ASA). Eur Respir J 2009; 34: Suppl. 53, 4564
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Reslizumab (RES) in asthma patients (pts) with severe eosinophilic asthma stratified by GINA asthma steps 4 and 5: Analysis of two phase 3, placebo (PBO)-controlled trials
Source: International Congress 2016 – Asthma management
Year: 2016
Effects of Omalizumab treatment on nasal symptoms (SNOT score) in patients treated for severe asthma.
Source: International Congress 2017 – Asthma management
Year: 2017
Symptom profile in obese asthmatics compared with non obese asthmatics in stable state
Source: Annual Congress 2013 –Asthma at the bedside
Year: 2013
Asthma control test (ACT) in outpatients and hospitalized patients with bronchial asthma
Source: Annual Congress 2009 - Asthma and comorbid conditions
Year: 2009
Endoscopic sinus surgery (ESS) attenuates aspirin-induced asthmatic reaction in patients with aspirin-intolerant asthma (AIA)
Source: Annual Congress 2007 - Airway regulation, provocation and monitoring I
Year: 2007
Efficacy of omalizumab in patients with moderate-to-severe allergic asthma that is poorly controlled on GINA (1998) treatment step 3 or 4
Source: Eur Respir J 2003; 22: Suppl. 45, 203s
Year: 2003
Eicosanoid concentrations in induced sputum (IS) in stable asthmatics with aspirin-tolerant (ATA) and aspirin-intolerant asthma (AIA)
Source: Eur Respir J 2005; 26: Suppl. 49, 575s
Year: 2005
Is the asthma control questionnaire (ACQ) usefull during acute moderate to severe (AMS) asthma exacerbations (AE)?
Source: Eur Respir J 2004; 24: Suppl. 48, 591s
Year: 2004
Omalizumab reduces asthma exacerbations in children (6–<12 years) with moderate-to-severe allergic (IgE-mediated) asthma irrespective of baseline LABA use
Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues
Year: 2009
The elderly subjects with asthma (ELSA) study. Asthma in subjects ≥65 yrs and its overlap with COPD
Source: Annual Congress 2013 –Is it really asthma?
Year: 2013
Clinical experience with montelukast plus ICS vs. only ICS in non-asthmatic eosinophilic bronchitis (NAEB) in Indian patients
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016
Evaluation of asthma patients using the control of allergic rhinitis and asthma test (CARAT)
Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma
Year: 2012
A comparison of clinical characteristics between cough variant asthma (CVA) and bronchial asthma (BA) in adult patients
Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up
Year: 2010
Efficacy of bronchial thermoplasty (BT) in patients with severe asthma: the AIR2 trial
Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009
Year: 2009
Applicability of the asthma control test (ACT) in elderly asthmatics
Source: Annual Congress 2008 - Basic science in asthma and COPD
Year: 2008
Omalizumab (Xolair®) reduces exacerbations in adolescents more than in adults with allergic (IgE-mediated) asthma: a subgroup analysis of pooled clinical trials
Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy
Year: 2008
Severity of allergic rhinitis and asthma control
Source: Annual Congress 2010 - Comorbidities and disease management in primary care
Year: 2010
Response to the combined therapy in COPD patients (pts) with different plasma surfactant protein D (SPD) level
Source: International Congress 2014 – COPD markers
Year: 2014
Validation of the ’test of the adherence to inhalers’ (TAI) for asthma and COPD patients
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015
Asthma control test (ACT) scores among asthmatics regularly attending outpatients
Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology II
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept